Home
Refresh   Tag(s): ; ; ; ; ; ; ; ; ; ; (more...) ; ; ; ; ; ;  (less...)
Add to My Group
January 25, 2007 at 13:35:28

View Ratings | Rate It

Eli Lilly The Habitual Offender

submit to twitter
submit to reddit
submit to digg
Tell A Friend

By Evelyn Pringle (about the author)     Page 3 of 3 page(s)

opednews.com     Permalink

In the case of Zyprexa, Lilly has so far settled with an estimated 26,000 plaintiffs, at a cost of over $1 billion. The incriminating documents leaked to the press last month, came to light during litigation with these plaintiffs but even after the litigation was settled, they were kept under seal with a court order.

Since the documents were made public, Lilly's legal team has spent about every other day in court trying to silence the messengers, Dr David Egilman and Jim Gottstein, and get the incriminating evidence back under seal, albeit without much success.

In a January 15, 2007, legal filing, a Lilly attorney quotes a comment by Judge Brian Cogan in a previous court hearing who said, Mr Gottstein had "deliberately and knowingly aided and abetted Dr. David Egilman's breach of CMO-3."

A responsive filing from Mr Gottstein should say that by issuing a protective order to suppress these documents to begin with, the court deliberately and knowingly aided and abetted Lilly in the off-label sale of Zyprexa by concealing the drug's side effects from tens of millions of consumers and prescribing physicians.


The secret documents show that Lilly concealed information about Zyprexa's link to severe weight gain, high blood sugar, and diabetes for a decade and because Lilly promoted Zyprexa off-label for so many uses, more than 20 million people have taken the drug. It is Lilly's best-selling product, with sales of about $30 billion since its arrival on the market in 1996, according to the January 20, 2007, New York Times.

In the latest development in the Zyprexa saga, last week Illinois and Vermont joined a coordinated five-state investigation of Lilly's marketing practices.

"The states are investigating whether Lilly tried to hide Zyprexa's risk of causing weight gain and other risks associated with diabetes and whether the company promoted Zyprexa for use in patients who do not have schizophrenia or bipolar disorder," the Times reports.

The larger question would seem to be, were the roughly 26,000 plaintiffs who entered into out-of-court settlements aware of the contents of the hidden documents and did they understand that by settling out of court Lilly would be permitted to keep the information secret knowing full well that more victims would be injured or killed by Zyprexa?

Information for injured parties can be found at Lawyers and Settlements.com
http://www.lawyersandsettlements.com:80/articles/zyprexa-misconduct.html

Evelyn Pringle
evelyn-pringle@sbcglobal.net

Next Page  1  |  2  |  3

 

Evelyn Pringle is a columnist for OpEd News and investigative journalist focused on exposing corruption in government and corporate America.

The views expressed in this article are the sole responsibility of the author
and do not necessarily reflect those of this website or its editors.

Contact Author Contact Editor View Authors' Articles

 

Share this page: (what's this?)                   Tell a Friend: Tell A Friend

FACEBOOK      DIGG THIS      Add This Page to Mr Wong!           NEWSVINE      DEl.ICIO.US      Looksmart Furl      NETSCAPE      My Web      Tag!RawSugar      Blink List     (More...)

Comments: Expand   Shrink   Hide  
1 comments
To view all comments:
Expand Comments
 

Zyprexa LIES by Danny Haszard on Thursday, Jan 25, 2007 at 2:12:52 PM

 
Want to post your own comment on this Article? Post Comment


 

 

 

Tell a Friend: Tell A Friend

Copyright © 2002-2009, OpEdNews

Powered by Populum